Immunologik

Developer of novel antiviral drug candidates targeting host cell structures

placeBerlin, Berlin, Germany calendar_todayFounded 2012 groups2 employees language immunologik.de

1 investor on record.

Investor type	Count	Share
Other / undisclosed	1	100%

Coming soon